Antigenics Inc.
Records under this name other than patents Antigenics Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,541,002 | Vaccine for treatment and prevention of herpes simplex virus infection Formerly held Lapsed on the fee record Ended Sep 24, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 24, 2025 | From the USPTO record |
| US 7,309,491 | Heat shock protein-based vaccines and immunotherapies Formerly held Term ended Term ended Apr 8, 2024 · From the USPTO record | Term ended | Term ended Apr 8, 2024 | From the USPTO record |
| US 7,420,037 | Heat shock protein-based vaccines and immunotherapies Formerly held Term ended Term ended Feb 12, 2024 · From the USPTO record | Term ended | Term ended Feb 12, 2024 | From the USPTO record |
| US 7,858,589 | Compositions of CpG and saponin adjuvants and uses thereof Term ended Term ended Mar 9, 2022 · From the USPTO record | Term ended | Term ended Mar 9, 2022 | From the USPTO record |
| US 7,049,302 | Compositions of CPG and saponin adjuvants and uses thereof Term ended Term ended Aug 6, 2019 · From the USPTO record | Term ended | Term ended Aug 6, 2019 | From the USPTO record |
| US 7,863,434 | Characterization of granulocytic Ehrlichia and methods of use Lapsed on the fee record Ended Jan 4, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jan 4, 2019 | From the USPTO record |
| US 6,284,238 | Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods Term ended Term ended Sep 4, 2018 · From the USPTO record | Term ended | Term ended Sep 4, 2018 | From the USPTO record |
| US 6,645,495 | Compositions of saponin adjuvants and excipients Term ended Term ended Aug 28, 2018 · From the USPTO record | Term ended | Term ended Aug 28, 2018 | From the USPTO record |
| US 6,204,252 | Characterization of granulocytic ehrlichia and methods of use Term ended Term ended Apr 24, 2018 · From the USPTO record | Term ended | Term ended Apr 24, 2018 | From the USPTO record |
| US 8,093,008 | Characterization of granulocytic ehrlichia and methods of use Term ended Ended no later than Apr 24, 2018 · From the USPTO record | Term ended | Ended no later than Apr 24, 2018 | From the USPTO record |